ArticleJournal of medical case reports2014
Chryseobacterium indologenes in a woman with acute leukemia in Senegal: a case report.
Article in Journal of medical case reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 20 citations in OpenAlex.
- ICEAntibiotics (Basel, Switzerland) · 2025Article
- A case of hospital-acquired pneumonia associated with Chryseobacterium indologenes infection in a patient with HIV infection and review of the literature.AIDS research and therapy · 2025Review
- Vaginal Infections during Pregnancy Increase Breast Milk Microbiome Alpha Diversity and Alter Taxonomic Composition.Preventive nutrition and food science · 2023Article
- First Isolation and Characterization ofPathogens (Basel, Switzerland) · 2020Article
- Chryseobacterium gleum in a man with prostatectomy in Senegal: a case report and review of the literature.Journal of medical case reports · 2017Review
- Whole genome sequencing for deciphering the resistome of Chryseobacterium indologenes, an emerging multidrug-resistant bacterium isolated from a cystic fibrosis patient in Marseille, France.New microbes and new infections · 2016Article
- Chryseobacterium indologenes: an emerging infection in the USA.BMJ case reports · 2016Review
- High-quality genome sequence and description of Chryseobacterium senegalense sp. nov.New microbes and new infections · 2016Article
- Ventilator-associated pneumonia caused bySpringerPlus · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis report documents a rare case of Chryseobacterium indologenes urinary tract infection in Senegal. Chryseobacterium indologenes is an uncommon human pathogen reported in hospital outbreaks in Taiwan and there have been some sporadic cases reported in Europe and in the USA mainly from immune-suppressed patients. CASE PRESENTATION: This case report describes a 42-year-old woman of Wolofa ethnicity who was hospitalized in our Department of Internal Medicine in a Senegalese university teaching hospital, with acute leukemia who died of severe sepsis 10 days following her hospitalization. A strain of Chryseobacterium indologenes isolated from her urine sample was resistant to several beta-lactams including ampicillin (minimum inhibitory concentrations ≥ 256 μg/mL), cefotaxime (minimum inhibitory concentrations 32 μg/mL) and imipenem (minimum inhibitory concentrations ≥ 32 μg/mL), whereas it was susceptible to piperacillin (minimum inhibitory concentrations 16 μg/mL), cefepime (minimum inhibitory concentrations 4 μg/mL), ceftazidime (minimum inhibitory concentrations 4 μg/mL), trimethoprim-sulfamethoxazole (minimum inhibitory concentrations ≤ 0.25 μg/mL) and all tested quinolones including nalidixic acid (minimum inhibitory concentrations ≤ 2 μg/mL).
conclusionsChryseobacterium indologenes although uncommon, is an important pathogen causing infection in hospitalized patients. The management of this infection needs better identification, drug susceptibility testing and monitoring of immunosuppressed patients with long hospitalizations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.